カテゴリ： MarketLine, フランス, 企業調査

Pernod Ricard SA：戦略・SWOT・企業財務分析

◆英語タイトル：Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015376
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：54
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Pernod Ricard SA – Strategy, SWOT and Corporate Finance Report
Summary

Pernod Ricard SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pernod Ricard SA (Pernod Ricard or ‘the group’) is engaged in the production and distribution of spirits and wines. The group operates in the Americas, Europe, and Asia. It is headquartered in Paris, France and employed 18,421 people as of June 30, 2015.

Scope

- Detailed information on Pernod Ricard SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pernod Ricard SA in the form of a SWOT analysis
- An in-depth view of the business model of Pernod Ricard SA including a breakdown and examination of key business segments
- Intelligence on Pernod Ricard SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pernod Ricard SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pernod Ricard SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pernod Ricard SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pernod Ricard SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Pernod Ricard SA: Company Overview
Pernod Ricard SA: Overview and Key Facts
Pernod Ricard SA: Overview
Pernod Ricard SA: Key Facts
Pernod Ricard SA: Key Employees
Pernod Ricard SA: Key Employee Biographies
Pernod Ricard SA: Major Products and Services
Pernod Ricard SA: Company History
Pernod Ricard SA: Management Statement
Pernod Ricard SA: Locations and Subsidiaries
Pernod Ricard SA: Key Competitors
Pernod Ricard SA: Company Analysis
Pernod Ricard SA: Business Description
Pernod Ricard SA: SWOT Analysis
Pernod Ricard SA: SWOT Overview
Pernod Ricard SA: Strengths
Pernod Ricard SA: Weaknesses
Pernod Ricard SA: Opportunities
Pernod Ricard SA: Threats
Pernod Ricard SA: Corporate Financial Deals Activity
Pernod Ricard SA: Financial Deals Overview
Pernod Ricard SA: Top Deals 2013 – 2017YTD*
Pernod Ricard SA: Advisors
Pernod Ricard SA: Top Legal Advisors
Pernod Ricard SA: Top Financial Advisors
Pernod Ricard SA: Capital Raising
Pernod Ricard SA: Divestments
Pernod Ricard SA: Recent Developments
Pernod Ricard SA: News and Events Summary
Pernod Ricard SA: Business Expansion
Pernod Ricard SA: Contracts
Pernod Ricard SA: Corporate Governance
Pernod Ricard SA: Financial Deals
Pernod Ricard SA: Financial Performance
Pernod Ricard SA: Market Developments
Pernod Ricard SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Pernod Ricard SA: Key Facts
Table 2: Pernod Ricard SA: Key Employees
Table 3: Pernod Ricard SA: Locations and Subsidiaries
Table 4: Pernod Ricard SA: Key Competitors
Table 5: Pernod Ricard SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Pernod Ricard SA: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Pernod Ricard SA: Top Deals 2013 - 2017YTD*
Table 8: Pernod Ricard SA: Legal Advisor Ranking by Value (US$m)
Table 9: Pernod Ricard SA: Financial Advisor Ranking by Value (US$m)
Table 10: Pernod Ricard SA: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 11: Pernod Ricard SA: Capital Raising by Deal Type (2013 - YTD*2017)
Table 12: Pernod Ricard SA: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 13: Pernod Ricard SA: Divestments by Geography (2013 - YTD*2017)
Table 14: Pernod Ricard SA: News and Events Summary
Table 15: Pernod Ricard SA: Business Expansion
Table 16: Pernod Ricard SA: Contracts
Table 17: Pernod Ricard SA: Corporate Governance
Table 18: Pernod Ricard SA: Financial Deals
Table 19: Pernod Ricard SA: Financial Performance
Table 20: Pernod Ricard SA: Market Developments
Table 21: Pernod Ricard SA: Strategy and Operations

★海外企業調査レポート[Pernod Ricard SA：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Lee Memorial Health System：企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Galecto Biotech AB-製薬・医療分野：企業M&A・提携分析
    Summary Galecto Biotech AB (Galecto Biotech) is a biotech company that focuses on the development of novel drugs for the treatment of fibrosis, inflammation, and other diseases. The company’s products act against galectins or galactoside binding lectins, a group of proteins that are involved in vari …
  • Western Gas Partners LP (WES)：石油・ガス：M&Aディール及び事業提携情報
    Summary Western Gas Partners LP (Western Gas), a subsidiary of Anadarko Petroleum Corp is an oil and gas company that acquires, owns, develops and operates midstream energy assets. The company's services include processing, compressing, gathering, treating and transporting natural gas, natural gas l …
  • Arkansas Children’s Hospital：企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Centrais Eletricas de Santa Catarina SA (CLSC4)：企業の財務・戦略的SWOT分析
    Centrais Eletricas de Santa Catarina SA (CLSC4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Magnolia Petroleum Plc (MAGP)：企業の財務・戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Inovalon Holdings Inc (INOV)：企業の財務・戦略的SWOT分析
    Summary Inovalon Holdings Inc (Inovalon), is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It offers Inovalon ONE platform and provides data dri …
  • Almac Group Ltd：企業のM&A・事業提携・投資動向
    Almac Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Almac Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • 3-D Matrix Ltd (7777)：製薬・医療：M&Aディール及び事業提携情報
    Summary 3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applica …
  • Broadwind Energy Inc (BWEN)：企業の財務・戦略的SWOT分析
    Broadwind Energy Inc (BWEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Iberdrola SA (IBE)：電力：M&Aディール及び事業提携情報
    Summary Iberdrola SA (Iberdrola) is an energy utility. It constructs, operates, and manages power generation plants, transmission and distribution facilities, and other assets. The company produces electricity using conventional and renewable energy sources. Iberdrola also trades electricity and gas …
  • Molson Coors Brewing Co (TAP)：企業の財務・戦略的SWOT分析
    Molson Coors Brewing Co (TAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Yum China Holdings Inc (YUMC)：企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Rio Grande Electric Cooperative, Inc.：発電所・企業SWOT分析
    Rio Grande Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Intuitive Surgical Inc (ISRG)：医療機器：M&Aディール及び事業提携情報
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The d …
  • Hawaii Biotech Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Hawaii Biotech Inc (Hawaii Biotech) is a biotechnology company that offers research and development of vaccines for established and emerging infectious diseases. The company's products include west nile virus vaccine, tick-borne flavivirus vaccine, malaria vaccine, and recombinant protein ex …
  • JHL Biotech Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • GenomeDx Biosciences Inc-医療機器分野：企業M&A・提携分析
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Bilfinger Tebodin BV：企業の戦略的SWOT分析
    Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • OBI Pharma Inc (4174)：医療機器：M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆